SecurMed UK announces appointment of Jerome Bertin as SecurMed UK General Manager
SecurMed UK is pleased to announce the appointment of Jerome Bertin as SecurMed UK General Manager from 01 January 2017.
Jerome brings a strong track record in business change, consulting and technology delivery from a commercial industry background. For the past eighteen months, Jerome has been leading packaging artwork and serialisation programmes for GlaxoSmithKline pharmaceutical and consumer health divisions, and has a good understanding of the challenges and complexities in implementing serialisation solutions for the medicines supply chain.
Prior to GlaxoSmithKline, Jerome spent 15 years in the oil & gas industry delivering enterprise scale business-to-business change, technology and infrastructure programmes for BP, Shell and BG Group. Jerome is professionally certified in Managing Successful Programmes (MSP) and as a PMI Project Management Professional.
The SecurMed UK Board looks forward to working with Jerome to deliver the SecurMed UK Medicines Verification System in 2019.
As the General Manager of SecurMed UK, Jerome will be responsible for the implementation of the UK repository and interfaces to time, and to budget, using an IT service provider (Blueprint Service Provider, or BSP) selected by the SecurMed UK Board.
Jerome will represent SecurMed UK in day-to-day business with medicines supply chain stakeholders, the UK Competent Authority, and other government and regulatory authorities and third parties in the four countries of the United Kingdom. He will also manage the SecurMed UK relationship with the European Medicines Verification Organisation (EMVO).
SecurMed UK is the UK Medicines Verification Organisation, a not-for-profit organisation which will deliver the UK Medicines Verification System. SecurMed UK has been incorporated by the principal representative supply chain stakeholder associations (Association of British Pharmaceutical Industry, British Association of European Pharmaceutical Distributors, British Generics Manufacturers Association, Company Chemists Association, Healthcare Distribution Association and National Pharmacy Association) as required by the EU Falsified Medicines Directive.